Trials / Conditions / Glomerulonephritis, IGA

Glomerulonephritis, IGA

21 registered clinical trials studyying Glomerulonephritis, IGA — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. NCT06858319	Novartis Pharmaceuticals	Phase 3
Recruiting	Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With Ig NCT06797518	Novartis Pharmaceuticals	Phase 2
Not Yet Recruiting	Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary Ig NCT06528015	Gang Xu	Phase 4
Recruiting	Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD NCT05510323	Air Force Military Medical University, China	Phase 3
Unknown	Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases NCT05797051	Qianfoshan Hospital	—
Recruiting	Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy NCT05791162	Centre Hospitalier Universitaire de Besancon	N/A
Active Not Recruiting	A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A NCT04663204	University of Leicester	Phase 2
Completed	The Clinical Trial of ADR-001 for IgA Nephropathy NCT04342325	Nagoya University	Phase 1
Unknown	Study of the IgA Repertoire During IgA Deposition Nephropathy. NCT04092491	University Hospital, Limoges	—
Terminated	A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) NCT03841448	Alnylam Pharmaceuticals	Phase 2
Unknown	Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency NCT04020328	Shenzhen Second People's Hospital	Phase 4
Terminated	Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy NCT02647255	Peking University First Hospital	Phase 2 / Phase 3
Completed	Efficacy and Safety of Losartan in Children With Ig A Nephropathy NCT02232776	Seoul National University Hospital	Phase 3
Unknown	A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes. NCT02160132	Sun Yat-sen University	Phase 2
Recruiting	Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) NCT01802034	The Rogosin Institute	—
Unknown	A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy NCT01184599	Kagawa University	Phase 4
Completed	Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy NCT00521508	Centre Hospitalier Universitaire de Saint Etienne	N/A
Completed	Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant NCT00446251	University of Washington	Phase 2
Completed	Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiti NCT00446459	University of Washington	Phase 2
Unknown	ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT NCT00378443	Peking University	N/A
Completed	Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy NCT00396721	Josep m Cruzado	Phase 2